Medicare's popular drug plan fills one of every four prescriptions in the U.S. But its lack of controls on heavy prescribing of name-brand drugs is wasting hundreds of millions every year.
Check back here for our new investigation into how encouraging cheaper generic alternatives could cut costs. We'll also be updating our Prescriber Checkup with 2011 data on 364,000 medical providers, so you can see how often your doctor prescribes name-brand drugs – and how he or she compares to peers.
Subscribe to ProPublica to be notified when we publish this story.
Thank you for your interest in republishing this story. You are are free republish it so long as you do the following:
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
If you’re republishing online, you have to link to us and to include all of the links from our story, as well as our PixelPing tag.
You can’t sell our material separately.
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
You cannot republish our photographs without specific permission (ask our Public Relations Director Minhee Cho if you’d like to).
You have to credit us — ideally in the byline. We prefer “Author Name, ProPublica.”
Copy and paste the following into your page to republish: